Notably, low pretreatment serum albumin levels in cancer patients are associated with poor survival [43,44,45], and low serum albumin levels are associated with poor response to various chemotherapies and tyrosine kinase inhibitors (TKIs) [46,47]. Here, ALB is linked to cancer.